Cargando…
Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication
Identifying drugs that regulate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its symptoms has been a pressing area of investigation during the coronavirus disease 2019 (COVID-19) pandemic. Nonsteroidal anti-inflammatory drugs (NSAIDs), which are frequently used for the...
Autores principales: | Chen, Jennifer S., Alfajaro, Mia Madel, Wei, Jin, Chow, Ryan D., Filler, Renata B., Eisenbarth, Stephanie C., Wilen, Craig B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523115/ https://www.ncbi.nlm.nih.gov/pubmed/32995789 http://dx.doi.org/10.1101/2020.09.24.312769 |
Ejemplares similares
-
Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection
por: Chen, Jennifer S., et al.
Publicado: (2021) -
DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner
por: Strine, Madison S., et al.
Publicado: (2023) -
The KDM6A-KMT2D-p300 axis regulates susceptibility to diverse coronaviruses by mediating viral receptor expression
por: Wei, Jin, et al.
Publicado: (2023) -
Cyclooxgenase-2 Inhibiting Perfluoropoly (Ethylene Glycol) Ether Theranostic Nanoemulsions—In Vitro Study
por: Patel, Sravan Kumar, et al.
Publicado: (2013) -
Tuft-cell-intrinsic and -extrinsic mediators of norovirus tropism regulate viral immunity
por: Strine, Madison S., et al.
Publicado: (2022)